Nestle

Last updated January 31, 2026

125

Innovation Areas

3,230

Inventors

Collaborations

Microrna mirna-3184 mirna-3126 bioactives: NestleRecent Research Landscape

Thermal processing of infant formulas triggers isomerization at the glucose reducing end, degrading nutritional value and shelf stability. These innovations control the chemical environment to prevent structural degradation during heat treatment.

What technical problems is Nestle addressing in Microrna mirna-3184 mirna-3126 bioactives?

Suboptimal early childhood neurodevelopment

(39)evidences

Inadequate cognitive regulation and irregular circadian rhythms in developing subjects. Addressing these physiological deficits ensures proper behavioral and biological development.

Infant enteral feeding intolerance

(9)evidences

Insufficient concentration of bioactive molecules at target sites. Improving delivery efficiency ensures consistent biological response and reduces required dosage.